Plasma levels and urinary excretion of vidarabine after repeated dosing.

Abstract

Vidarabine (Vira-A) was given intravenously for 5 days to 5 immunosuppressed patients with herpes zoster. The daily dose, 10 mg/kg, was given by slow infusion over 12 hr. Blood samples were taken at 0, 1, 2, 4, 8, and 12 hr on days 1, 3, and 5. Twenty-four-hour urine specimens were collected before treatment and on days 1, 3, and 5. Blood and urine… (More)

Topics

Cite this paper

@article{Buchanan1980PlasmaLA, title={Plasma levels and urinary excretion of vidarabine after repeated dosing.}, author={Rebecca A. Buchanan and A. W. Kinkel and Charles A. Alford and Richard J. Whitley}, journal={Clinical pharmacology and therapeutics}, year={1980}, volume={27 5}, pages={690-6} }